Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Exophthalmos”

318 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 318 results

Large-scale testing (Phase 3)UnknownNCT01616108
What this trial is testing

Bupivacaine Injection of Eye Muscles to Treat Strabismus

Who this might be right for
StrabismusEsotropiaExotropia+2 more
Smith-Kettlewell Eye Research Institute 120
Not applicableUnknownNCT02210741
What this trial is testing

Next-generation Sequencing (NGS) of Peripheral Blood Immune Repertoire in Graves' Disease

Who this might be right for
Graves Disease
National Taiwan University Hospital 200
Not applicableLooking for participantsNCT07410637
What this trial is testing

Impact of Thyroid Hormones on Human Glucose and Energy Metabolism

Who this might be right for
Graves DiseaseThyroid Cancer
University of Ulm 60
Testing effectiveness (Phase 2)Looking for participantsNCT07682896
What this trial is testing

Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease

Who this might be right for
Graves' Disease
Yarrow Bioscience, Inc. 232
Not applicableStudy completedNCT03278964
What this trial is testing

Analysis Between the Results of Two Surgical Techniques of Orbital Decompression in Patients With Graves Orbitopathy

Who this might be right for
Graves Ophthalmopathy
University of Sao Paulo General Hospital 42
Post-approval studies (Phase 4)Looking for participantsNCT07265258
What this trial is testing

Teprotumumab N01 in Subjects With Active Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Innovent Biologics (Suzhou) Co. Ltd. 92
Not applicableEnded earlyNCT05964452
What this trial is testing

Efficacy of Methimazole Dosing Algorithm

Who this might be right for
Graves Disease
Cook County Health 11
Not applicableLooking for participantsNCT05012033
What this trial is testing

Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting

Who this might be right for
Thyroid Eye DiseaseVasculitisCOPD Exacerbation Acute+2 more
Imperial College London 120
Not applicableUnknownNCT04710485
What this trial is testing

Sphenoorbital Meningioma Management.

Who this might be right for
Brain Meningioma
Assiut University 24
Large-scale testing (Phase 3)Looking for participantsNCT03131726
What this trial is testing

Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)

Who this might be right for
Graves OphthalmopathyThyroid Associated OphthalmopathyThyroid Associated Orbitopathy
Lund University 80
Large-scale testing (Phase 3)Ended earlyNCT04737330
What this trial is testing

The Efficacy and Safety of Secukinumab 300 mg in Patients With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye DiseaseGraves Orbitopathy
Novartis Pharmaceuticals 28
Early research (Phase 1)Study completedNCT06674941
What this trial is testing

A Trial to Investigate Teprotumumab (High-concentration Formulation) Subcutaneous Administration in Healthy Adult Non-Japanese and Japanese Participants

Who this might be right for
Healthy Volunteers
Amgen 44
Post-approval studies (Phase 4)Study completedNCT00150137
What this trial is testing

Antithyroid Drugs During Radioiodine Therapy

Who this might be right for
Toxic Nodular GoitreGraves Disease
Odense University Hospital 80
Not applicableStudy completedNCT01798966
What this trial is testing

Twenty-four Hour Intraocular Pressure Patterns in Patients With Uncontrolled Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Sensimed AG 10
Not applicableEnded earlyNCT02316691
What this trial is testing

B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
University of Pittsburgh 2
Large-scale testing (Phase 3)Active Not RecruitingNCT06625398
What this trial is testing

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 204
Large-scale testing (Phase 3)Looking for participantsNCT07570316
What this trial is testing

Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease

Who this might be right for
Graves' DiseaseGraves Disease
argenx 230
Post-approval studies (Phase 4)Looking for participantsNCT05461820
What this trial is testing

Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease

Who this might be right for
Graves DiseaseRelapseTreatment+1 more
The First Affiliated Hospital with Nanjing Medical University 240
Post-approval studies (Phase 4)Study completedNCT03948191
What this trial is testing

99Tc-MDP for Thyroid-Associated Ophthalmopathy

Who this might be right for
Thyroid-Associated Ophthalmopathy
Dalian University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT06088979
What this trial is testing

Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Tourmaline Bio, Inc., a Novartis Company 79
Next Page